Overview

To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
To demonstrate the relative bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg ER tablets under fed conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Cetirizine
Ephedrine
Pseudoephedrine